
HCW Biologics fell 94.7% from $14.46 to $0.76, behind the S&P 500's +10.6%. Its worst day was Mar 23 (−29.9%), and its low came Nov 18 at $0.76.
Nov 18, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
HCW Biologics shares rose 79.0%, while the S&P 500 rose 1.0%.
+79.0%, on 77M shares, the year's heaviest volume · S&P 500 +1.0%
Story events cover the past 12 months · Times ET
EPS of $-6.12 missed the $-5.04 estimate on $27,010.00 revenue (est. $7.0M).
−16.7% · S&P 500 +0.8%
EPS of $2.22 beat the $-2.64 estimate on $6.5M revenue.
+262.0%, the year's best day · S&P 500 −1.2%
EPS of $-11.58 missed the $-1.98 estimate on $135,568.00 revenue.
−8.4% · S&P 500 −0.2%
EPS of $-2.83 beat the $-8.10 estimate on $55,463.00 revenue.
+3.9% · S&P 500 −1.9%
Where it ended: a close of $0.76 on Nov 18, 2026.
Nothing in the past 12 months.
All HCWB dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HCWB and SPY from Benzinga historical bars. Not investment advice.